Latest RxSight Inc. (RXST) News on January 24, 2025
MT Newswires
a month ago
Stifel Downgrades RxSight to Hold From Buy, Adjusts Price Target to $40 From $65
Simply Wall St.
a month ago
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year
MT Newswires
a month ago
Wells Fargo Downgrades RxSight to Equal Weight From Overweight, $56 Price Target
MT Newswires
2 months ago
RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing
Simply Wall St.
2 months ago
RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
GuruFocus.com
2 months ago
RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ...
GlobeNewswire
3 months ago
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
MT Newswires
3 months ago
Rxsight Insider Sold Shares Worth $309,850, According to a Recent SEC Filing
MT Newswires
3 months ago
Rxsight Insider Sold Shares Worth $462,458, According to a Recent SEC Filing
Insider Monkey
3 months ago
RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now
MT Newswires
4 months ago
RxSight Insider Sold Shares Worth $328,164, According to a Recent SEC Filing
Simply Wall St.
4 months ago
Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation
GlobeNewswire
5 months ago
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
MT Newswires
5 months ago
Needham Raises Price Target on RxSight to $66 From $54, Adds Stock to Conviction List, Keeps Buy Rating
Simply Wall St.
6 months ago
US$63.00: That's What Analysts Think RxSight, Inc. (NASDAQ:RXST) Is Worth After Its Latest Results
MT Newswires
6 months ago
Oppenheimer Adjusts RxSight Price Target to $65 From $72, Maintains Outperform Rating
MT Newswires
6 months ago
RxSight Reports Breakeven Q2 Adjusted Earnings as Revenue Increases; Raises 2024 Revenue Guidance
Simply Wall St.
6 months ago
Exploring Undervalued Small Caps With Insider Action In The United States July 2024
GlobeNewswire
6 months ago
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
Investor's Business Daily
6 months ago
Dow Jones Jumps 429 Points On Fed Chief's Comments; Gold Miners, Chips Rally (Live Coverage)
MT Newswires
6 months ago
Stifel Adjusts Price Target on RxSight to $70 From $75, Maintains Buy Rating
MT Newswires
7 months ago
RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing
GuruFocus.com
7 months ago
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
Investor's Business Daily
7 months ago
Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock
Investor's Business Daily
8 months ago
These 5 Companies Lost Money. Here's Why They're Still On The IBD 50.
Investor's Business Daily
8 months ago
Why Top-Rated Medtech RxSight Has 20/20 Vision — And Is Seeing 55% Growth
MT Newswires
8 months ago
Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing
Simply Wall St.
8 months ago
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
MT Newswires
9 months ago
Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating
MT Newswires
9 months ago
Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating
MT Newswires
9 months ago
Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating
MT Newswires
9 months ago
BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating
GuruFocus.com
9 months ago
RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
MT Newswires
9 months ago
Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing
MT Newswires
9 months ago
Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing
GlobeNewswire
10 months ago
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Simply Wall St.
a year ago
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$57.75
GlobeNewswire
a year ago
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
GuruFocus.com
a year ago
RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023
GlobeNewswire
a year ago
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Business Wire
a year ago
RXO Announces Participation at Barclays 41st Annual Industrials Select Conference
